ANPAC Bio-Medical launching new facility in Pennsylvania.
U.S. Technical Team

Technical Advisory Board Members

DR. LEE P. SHULMAN

DR. LEE P. SHULMAN

TECHNICAL BOARD CONSULTANT

Dr. Shulman is the Chief of the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University

DR. JOHN J. REDDINGTON

DR. JOHN J. REDDINGTON

TECHNICAL BOARD CONSULTANT

Dr. Reddington was the former Chief Operating Officer for Cambridge Biomedical Inc., a privately held laboratory CRO

DR. H. MICHAEL SHEPARD

DR. H. MICHAEL SHEPARD

TECHNICAL BOARD CONSULTANT

Dr. Shepard shared the 2006 Alpert Prize for his contribution to the development of the breast cancer therapy Herceptin, the first target-directed cancer treatment for solid tumors.

Research Laboratory Team

ALFRED LUI, M. D., FCAP

ALFRED LUI, M. D., FCAP

CLIA LABORATORY DIRECTOR

Dr. Lui is an American Board of Pathology diplomat certified in anatomic and clinical pathology, and he has extensive experience as the Director of CLIA certified and CAP accredited laboratories.

SHARON VORSE-YU, M.S.

SHARON VORSE-YU, M.S.

VP of Technical Operations

Sherry's focus is on bio-medical CLIA lab set-up and certification. She is responsible for working, on a technical level, with Anpac Bio’s medical groups and hospital partners, and with our leading medical and bio-science university partners.